Medifast Inc (MED) Stock Price, Quote & News

Company Profile

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, essential amino acid blends, whey protein, hot beverages, brownies, and mini m...

Industry: Personal Services

Sector: Consumer Cyclical

Phone: 410 581 8042

Website: medifastinc.com

Address:

100 International Drive, 18th Floor, Baltimore, United States

justcomments Mar. 20 at 7:13 PM

$MED some shmuck got squeezed here today at about 5 minutes to 1pm EST. That's typical in crash scenarios. Shorts must close, because their portfolios are stretching tight in crashes. While it's not guaranteed - but MED could creep up a bit using this as a sail. The market might as well crash tomorrow - so expect eventual fireworks here for tomorrow. And by far - this is not a recomendation to purchase, just a thought. MED is somewhat heavy with shorts.

0 · Reply

Amolosricha1 Mar. 12 at 6:33 PM

$MED under 10 I bought some shares :D. Now, I am eyeing something irrational like 8 or something like that.

1 · Reply

_StockFox_ Mar. 12 at 2:13 PM

$MED uhoh under $10…low float.. $SPY $QQQ

0 · Reply

Amolosricha1 Mar. 11 at 9:10 PM

$MED It's trading at 67% of cash on hand. That makes no sense. A few years back the company had growth rates over 40%/y. Expectation is very low, now. It's valued below bankruptcy levels. Or what do you think cash would be liquidated for? The market values the company as if it would burn through all the cash and even more. In fact, if they would end the business tomorrow and pay out the cash, you should actually make money. That's how irrational the price is. The market clearly misses the opportunity that growth could make a come back. The market ignores the strategic shift Medifast has taken to metabolic health. It's not only weight loss anymore and GLP-1 disruption is in weight loss. The market misses improvements in coach productivity. That's why, I think the downside potential is limited and the upside potential is huge.

0 · Reply

justcomments Mar. 11 at 5:33 PM

$MED I got a new stock pick - for the time being when this POS relaxes before the deserved takeoff. Anyone interested?

1 · Reply

Amolosricha1 Mar. 10 at 6:19 PM

$MED I hope that this explodes. I'm ready.

0 · Reply

Estimize Mar. 4 at 2:03 PM

Wall St is expecting -0.52 EPS for $MED Q1 [Reporting 05/04 AMC] http://www.estimize.com/intro/med?chart=historical&metric_name=eps&utm_con

0 · Reply

justcomments Mar. 3 at 8:04 PM

$MED shook my previous fundamental valuation beliefs. It is really a bad combination of circumstances and it is possible that it works out well for them, but it is also possible that it won't. Yes, if this company - somehow, I don't know how - but somehow starts to grow, then my gosh - it might be a hit. But I see absolutely no catalysts for that whatsoever. Do you? How? I am a shareholder here for 2 years already and in my judgement it is bad. They would be better off investing in real estate or something. Take that $160M+ and put it in HY bonds. Whatever. Just do something. Do something smart. SMART. But will they? Man..

1 · Reply

Amolosricha1 Mar. 2 at 6:14 PM

$MED downside potential is limited and the upside potential is huge. It easily could multi X from here.

0 · Reply

Amolosricha1 Feb. 20 at 4:08 PM

$MED I bought some shares, today. If it dips I will buy more.

1 · Reply

Medifast Announces Cooperation Agreement with Steamboat Capital

Feb 20, 2026, 8:30 AM EST - 4 weeks ago

Scientific Evidence Demonstrates OPTAVIA®'s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients

Feb 17, 2026, 6:24 PM EST - 4 weeks ago

Medifast, Inc. (MED) Q4 2025 Earnings Call Transcript

Feb 17, 2026, 4:05 PM EST - 4 weeks ago

Medifast Announces Fourth Quarter and Full Year 2025 Financial Results

Feb 4, 2026, 10:26 AM EST - 6 weeks ago

Medifast Is A Net-Net With Negative Enterprise Value

Feb 3, 2026, 4:05 PM EST - 6 weeks ago

Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025

Jan 16, 2026, 8:30 AM EST - 2 months ago

People Magazine Spotlights Tiffany Howard's Metabolic Health Journey with OPTAVIA®

Jan 15, 2026, 8:30 AM EST - 2 months ago

OPTAVIA® Premieres Second Docuseries Episode “Health by Design: Spain” Exploring Metabolic Health and Longevity

Jan 5, 2026, 9:00 AM EST - 2 months ago

Medifast Announces Planned Leadership Transition

Dec 9, 2025, 8:30 AM EST - 3 months ago

OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing

Nov 13, 2025, 4:30 PM EST - 4 months ago

Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference

Nov 3, 2025, 6:36 PM EST - 4 months ago

Medifast, Inc. (MED) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 4:05 PM EST - 4 months ago

Medifast Announces Third Quarter 2025 Financial Results

Oct 27, 2025, 8:30 AM EDT - 5 months ago

Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™

Oct 21, 2025, 10:00 AM EDT - 5 months ago

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025

Sep 15, 2025, 8:30 AM EDT - 6 months ago

Evidence Links 5 & 1 Plan® to Improved Metabolic Health Outcomes

Aug 4, 2025, 11:56 PM EDT - 8 months ago

Medifast, Inc. (MED) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 4:05 PM EDT - 8 months ago

Medifast Announces Second Quarter 2025 Financial Results

LFMD

Jul 21, 2025, 4:05 PM EDT - 8 months ago

Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025

Jul 3, 2025, 2:48 AM EDT - 9 months ago

Medifast: Coach Surge Fuels Growth

Apr 28, 2025, 6:03 PM EDT - 11 months ago

Medifast, Inc. (MED) Q1 2025 Earnings Call Transcript

Apr 28, 2025, 4:05 PM EDT - 11 months ago

Medifast Announces First Quarter 2025 Financial Results

LFMD

Mar 28, 2025, 9:21 AM EDT - 1 year ago

Medifast: GLP-1 Caused A Vicious MLM Flywheel Effect

Feb 18, 2025, 7:06 PM EST - 1 year ago

Medifast, Inc. (MED) Q4 2024 Earnings Call Transcript

Feb 18, 2025, 4:05 PM EST - 1 year ago

Medifast Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 4, 2025, 4:05 PM EST - 1 year ago

Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024

Jan 7, 2025, 8:30 AM EST - 1 year ago

Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off

Dec 5, 2024, 8:30 AM EST - 1 year ago

Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential – Even with Weight Loss Medications

Nov 6, 2024, 8:02 AM EST - 1 year ago

Medifast: Earnings Surprise, New AI Technologies, And Extremely Undervalued

Nov 4, 2024, 5:56 PM EST - 1 year ago

Medifast, Inc. (MED) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 4:05 PM EST - 1 year ago

Medifast Announces Third Quarter 2024 Financial Results

Oct 21, 2024, 4:05 PM EDT - 1 year ago

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024

Oct 3, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Encourages Shareholder Participation In A Securities Fraud Inquiry Into Medifast, Inc.

Oct 1, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Shareholders To Join An Inquiry Into Medifast, Inc. For Possible Securities Fraud

Sep 30, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Is Being Investigated For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm

Sep 28, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Is Being Investigated For Violating Securities Laws And Investors With Losses Are Urged To Contact The Schall Law Firm

Sep 27, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Invites Shareholder Participation In A Securities Fraud Inquiry Into Medifast, Inc.

Sep 26, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Is Being Investigated For Violating Securities Laws And Investors Are Urged To Contact The Schall Law Firm

Sep 25, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Medifast, Inc. For Possible Securities Fraud

Sep 24, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Is Being Investigated For Violating Securities Laws And Affected Investors Are Urged To Contact The Schall Law Firm

Sep 21, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Medifast, Inc. For Securities Fraud

Sep 20, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc May Have Violated Securities Laws And Investors Are Urged To Help The Schall Law Firm Investigate

Sep 19, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Seeks Shareholder Participation In An Inquiry Into Medifast, Inc. For Possible Securities Fraud

Sep 17, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Seeks Shareholder Contributions To A Securities Fraud Inquiry Into Medifast, Inc.

Sep 15, 2024, 11:00 AM EDT - 1 year ago

Medifast, Inc. May Have Defrauded The Public And The Schall Law Firm Invites Stockholders To Join A Securities Fraud Inquiry

$The Schall Law Firm Is Investigating Medifast Inc's Possible Securities Related Infractions And Affected Investors Can Partake$

Sep 14, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Investigating Medifast Inc's Possible Securities Related Infractions And Affected Investors Can Partake

Sep 13, 2024, 11:00 AM EDT - 1 year ago

Medifast, Inc. May Have Committed Securities Fraud And Shareholders With Losses Are Urged To Contribute To The Schall Law Firm's Inquiry

justcomments Mar. 20 at 7:13 PM

0 · Reply

Amolosricha1 Mar. 12 at 6:33 PM

$MED under 10 I bought some shares :D. Now, I am eyeing something irrational like 8 or something like that.

1 · Reply

_StockFox_ Mar. 12 at 2:13 PM

$MED uhoh under $10…low float.. $SPY $QQQ

0 · Reply

Amolosricha1 Mar. 11 at 9:10 PM

0 · Reply

justcomments Mar. 11 at 5:33 PM

$MED I got a new stock pick - for the time being when this POS relaxes before the deserved takeoff. Anyone interested?

1 · Reply

Amolosricha1 Mar. 10 at 6:19 PM

$MED I hope that this explodes. I'm ready.

0 · Reply

Estimize Mar. 4 at 2:03 PM

Wall St is expecting -0.52 EPS for $MED Q1 [Reporting 05/04 AMC] http://www.estimize.com/intro/med?chart=historical&metric_name=eps&utm_con

0 · Reply

justcomments Mar. 3 at 8:04 PM

1 · Reply

Amolosricha1 Mar. 2 at 6:14 PM

$MED downside potential is limited and the upside potential is huge. It easily could multi X from here.

0 · Reply

Amolosricha1 Feb. 20 at 4:08 PM

$MED I bought some shares, today. If it dips I will buy more.

1 · Reply

justcomments Feb. 19 at 6:00 PM

$MED My honest assessment here is that people worry too much now. Yeah, the company is a piece of s. Yes the results were terrible. Yes they have no real shot at earnings here in 2026. But everybody know that now - including these people who knew earlier - mid January. So unless you have 5% of this shitty stock - then I would not worry at all. Who cares where it lands now? Maybe 9. But there is a significant chance that it recovers in 2027. I am not selling here. It will bounce. Just need the sellers to sell, or sober up and be done with it and it will get back to 11 fast.

1 · Reply

Amolosricha1 Feb. 19 at 5:40 PM

$MED I see this going bellow $10 soon

1 · Reply

justcomments Feb. 19 at 5:38 PM

$MED this stock has momentum in the wrong direction. Very high risk investment when you think about it. We are at the significant low today and yet there is plenty of sellers, who seem to only dream about getting out. The supply is not trivial either. I recall the total number of people who logged in the ER call was just 5 here. So I am wondering - who took such enormous risk by buying big into this illiquid security with such a risky set of circumstances.

0 · Reply

fer69 Feb. 19 at 12:46 PM

$MED I’m glad I always initiate positions in small chunks … this one had been one of my worst buys together with $PETS .. down like 40% on this POS. not averaging down either .. no putting more money on this until they start showing a real turn around

0 · Reply

justcomments Feb. 19 at 1:38 AM

$MED now what? Oh man. What a pain in the butt this is.

0 · Reply

Amolosricha1 Feb. 18 at 5:31 PM

$MED I expected the price to go down but it's not going down. I need to buy some cheap shares :). Bellow $10 would be nice.

0 · Reply

ZacksResearch Feb. 18 at 5:12 PM

$MED Q4 results: Revenue beats but EPS misses the mark 📉 MED reported a quarterly loss of $1.65 per share, missing the Zacks Consensus Estimate of a loss of 76 cents. Net revenues declined 36.9% year over year due to fewer active earning OPTAVIA coaches, though it surpassed estimates at $75.1M. Full breakdown here 👉 https://www.zacks.com/stock/news/2871368/medifast-q4-loss-wider-than-expected-revenues-decline-37-yy?cid=sm-stocktwits-2-2871368-body-34070&ADID=SYND_STOCKTWITS_TWEET_2_2871368_BODY_34070

0 · Reply

ZacksResearch Feb. 18 at 4:12 PM

$MED just posted a rough quarter — and the numbers aren’t pretty ⚠️ Q4 loss came in wider than expected, with revenue down 36.9% year over year driven by a sharp drop in OPTAVIA coaches. Even though revenue beat estimates, the top-line slide and deeper loss tell the real story. Is this a turnaround setup or more pain ahead? Full breakdown 👉 https://www.zacks.com/stock/news/2871368/medifast-q4-loss-wider-than-expected-revenues-decline-37-yy?cid=sm-stocktwits-2-2871368-teaser-34055&ADID=SYND_STOCKTWITS_TWEET_2_2871368_TEASER_34055

0 · Reply

justcomments Feb. 17 at 11:50 PM

$MED transcript https://www.fool.com/earnings/call-transcripts/2026/02/17/medifast-med-q4-2025-earnings-call-transcript/

0 · Reply

d_risk Feb. 17 at 11:45 PM

$MED - MEDIFAST INC - 10K - Updated Risk Factors MED’s 2026 10-K risks pivot hard to “metabolic health,” flagging intensifying competition (including GLP-1 drugs, wearables, diet products), execution risk on a new holistic strategy, dependence and regulatory pressure on its coach-based direct selling model, heavier IT/cyber and AI threats, concentrated supply chain and product liability exposure, greater IP and data-privacy litigation risk, and sharpened concerns over internal controls as several prior stock-related risk factors are pared back or removed. #MetabolicHealth #DirectSellingRisks #RegulatoryPressure #CybersecurityThreats #SupplyChainConcentration 🟢 Added 🟠 Removed https://d-risk.ai/MED/10-K/2026-02-17

0 · Reply

StocktwitsEarnings Feb. 17 at 9:51 PM

$MED Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$1.65 down -2457.14% YoY • Reported revenue of $75.1M down -36.90% YoY • Medifast expects first quarter 2026 revenue to be in the range of $65M to $80M, with a loss per share from $0.15 to $0.70. For full year 2026, Medifast anticipates revenue between $270M and $300M and loss per share from $1.55 to $2.75.

0 · Reply

DonCorleone77 Feb. 17 at 9:16 PM

$MED Medifast sees Q1 EPS (70c)-(15c) Sees Q1 revenue $65M-$80M

0 · Reply

Market Cap	109.91M
Revenue (ttm)	385.79M
Net Income (ttm)	-18.67M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-4.84%
Debt to Equity Ratio	0.00

Volume	701,300
Avg Vol	255,610
Day's Range	N/A - N/A
Shares Out	10.99M
Stochastic %K	47%
Beta	0.52
Analysts	Hold
Price Target	$12.00